| 1 |
Posttransplant hypertension: Multipathogenic disease process |
|
|
| Barbari, A. |
|
| Experimental and Clinical Transplantation. 2013; 11(2): 99-108 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients |
|
|
| Rostami, Z. and Einollahi, B. and Teimoori, M. |
|
| Iranian Journal of Kidney Diseases. 2012; 6(5): 373-379 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients |
|
|
| Sarangi, S.C. and Reeta, K.H. and Agarwal, S.K. and Kaleekal, T. and Guleria, S. and Gupta, Y.K. |
|
| Indian Journal of Medical Research. 2012; 135(1): 84-91 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients |
|
|
| Basso, M.-S. and Subramaniam, P. and Tredger, M. and Verma, A. and Heaton, N. and Rela, M. and Mieli-Vergani, G. and Dhawan, A. |
|
| Pediatric Transplantation. 2011; 15(7): 722-727 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Effects of cyclosporine A and tacrolimus on blood lipid of renal transplant recipients |
|
|
| Guo, J. and Qu, Q.-S. and Zhu, M.-H. and Liu, X.-H. |
|
| Journal of Clinical Rehabilitative Tissue Engineering Research. 2010; 14(44): 8207-8210 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Expression and significance of transforming growth factor-beta 1, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the renal tissue of patients with chronic allograft nephropathy |
|
|
| Han, C.-X. and Xie, Q.-X. and Zhao, L. and Li, J.-Y. and Lin, X.-C. |
|
| Journal of Clinical Rehabilitative Tissue Engineering Research. 2009; 13(5): 821-824 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Reducing calcineurin inhibitor and adding Sirolimus to treat chronic allograft nephropathy |
|
|
| Huo, W.-Q. and Li, Q.-S. and Jin, F.-S. and Nie, Z.-L. and Zhu, F.-Q. and Zhang, K.-Q. |
|
| Journal of Clinical Rehabilitative Tissue Engineering Research. 2008; 12(53): 10453-10456 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation |
|
|
| Danger, R. and Giral, M. and Soulillou, J.-P. and Brouard, S. |
|
| Current Opinion in Organ Transplantation. 2008; 13(6): 609-613 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin |
|
|
| Hoogduijn, M.J. and Crop, M.J. and Korevaar, S.S. and Peeters, A.M.A. and Eijken, M. and Maat, L.P.W.M. and Balk, A.H.M.M. and Weimar, W. and Baan, C.C. |
|
| Transplantation. 2008; 86(9): 1283-1291 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Gingival status of Brazilian renal transplant recipients under sirolimus-based regimens |
|
|
| Cota, L.O.M. and Oliveira, A.P.L. and Costa, J.E. and Cortelli, S.C. and Costa, F.O. |
|
| Journal of Periodontology. 2008; 79(11): 2060-2068 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Health-related quality of life in adult transplant recipients more than 15 years after orthotopic liver transplantation |
|
|
| Kousoulas, L. and Neipp, M. and Barg-Hock, H. and Jackobs, S. and Strassburg, C.P. and Klempnauer, J. and Becker, T. |
|
| Transplant International. 2008; 21(11): 1052-1058 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Immune modulation in corneal transplantation |
|
|
| Fu, H. and Larkin, D.F.P. and George, A.J.T. |
|
| Transplantation Reviews. 2008; 22(2): 105-115 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
A novel approach in clinical immunosuppression monitoring: Drug lymphocyte level |
|
|
| Barbari, A. and Masri, M. and Stephan, A. and Rizk, S. and Younan, F. |
|
| Experimental and Clinical Transplantation. 2007; 5(2): 643-648 |
|
| [Pubmed] [Google Scholar] |
|
